Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, Porath M, Oudijk MA, Bloemenkamp KW, Groot CJ, van Beek E, van Huizen ME, Oosterbaan HP, Willekes C, Wijnen-Duvekot EJ, Franssen MT, Perquin DA, Sporken JM, Woiski MD, Bremer HA, Papatsonis DN, Brons JT, Kaplan M, Nij Bijvanck BW, Mol BW; HYPITAT-II study group. Langenveld J, et al. Among authors: bremer ha. BMC Pregnancy Childbirth. 2011 Jul 7;11:50. doi: 10.1186/1471-2393-11-50. BMC Pregnancy Childbirth. 2011. PMID: 21736705 Free PMC article. Clinical Trial.
Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).
Boers KE, Vijgen SM, Bijlenga D, van der Post JA, Bekedam DJ, Kwee A, van der Salm PC, van Pampus MG, Spaanderman ME, de Boer K, Duvekot JJ, Bremer HA, Hasaart TH, Delemarre FM, Bloemenkamp KW, van Meir CA, Willekes C, Wijnen EJ, Rijken M, le Cessie S, Roumen FJ, Thornton JG, van Lith JM, Mol BW, Scherjon SA; DIGITAT study group. Boers KE, et al. Among authors: bremer ha. BMJ. 2010 Dec 21;341:c7087. doi: 10.1136/bmj.c7087. BMJ. 2010. PMID: 21177352 Free PMC article. Clinical Trial.
Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial.
Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, Akerboom BM, van Alphen M, Bloemenkamp KW, Boers KE, Bremer HA, Kwee A, van Loon AJ, Metz GC, Papatsonis DN, van der Post JA, Porath MM, Rijnders RJ, Roumen FJ, Scheepers HC, Schippers DH, Schuitemaker NW, Stigter RH, Woiski MD, Mol BW, van Rhenen DJ, Duvekot JJ. Prick BW, et al. Among authors: bremer ha. BJOG. 2014 Jul;121(8):1005-14. doi: 10.1111/1471-0528.12531. Epub 2014 Jan 10. BJOG. 2014. PMID: 24405687 Clinical Trial.
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huizen ME, Vredevoogd CB, Brons J, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J; HYPITAT-II Study Group. van Baaren GJ, et al. Among authors: bremer ha. BJOG. 2017 Feb;124(3):453-461. doi: 10.1111/1471-0528.13957. Epub 2016 Mar 10. BJOG. 2017. PMID: 26969198 Clinical Trial.
Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, van Loon AJ, van Pampus MG, Rijnders RJP, Sikkema MJ, Scherjon SA, Woiski MD, Mol BWJ, van Baar AL, Groen H; HYPITAT-II Study Group. Zwertbroek EF, et al. Am J Obstet Gynecol. 2019 Aug;221(2):154.e1-154.e11. doi: 10.1016/j.ajog.2019.03.024. Epub 2019 Mar 30. Am J Obstet Gynecol. 2019. PMID: 30940558 Clinical Trial.
Ketonuria is not associated with hyperemesis gravidarum disease severity.
Koot MH, Grooten IJ, Post JAMV, Bais JMJ, Ris-Stalpers C, Naaktgeboren CA, Niemeijer MN, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Koot MH, et al. Among authors: bremer ha. Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:315-320. doi: 10.1016/j.ejogrb.2020.08.014. Epub 2020 Aug 26. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 33045502
Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up.
Simons NE, van Limburg Stirum EVJ, van Wassenaer-Leemhuis AG, Finken MJJ, Aarnoudse-Moens CSH, Oosterlaan J, van Baar A, Roseboom TJ, Lim AC, van Wely M, de Boer MA, Painter RC, Pajkrt E, Oudijk MA, van T Hooft J; AMPHIA study group. Simons NE, et al. BMJ Open. 2021 Sep 21;11(9):e053066. doi: 10.1136/bmjopen-2021-053066. BMJ Open. 2021. PMID: 34548367 Free PMC article.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
40 results